American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 1-6 , July 2008

Obesity and CKD: How to Assess the Risk?

  • Eberhard Ritz, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Eberhard Ritz, MD, Nierenzentrum, Im Neuenheimer Feld 162, Heidelberg, Germany D 60100.

References 

  1. Praga M. Obesity—a neglected culprit in renal disease. Nephrol Dial Transplant. 2002;17:1157–1159
  2. Bonnet F, Deprele C, Sassolas A, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis. 2001;37:720–727
  3. Morales E, Valero MA, Leon M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 2003;41:319–327
  4. Bello AK, de Zeeuw D, El Nahas M, et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant. 2007;22:1619–1627
  5. Chagnac AWT, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–F822
  6. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med. 1974;81:440–447
  7. Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–1509
  8. Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–1876
  9. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28
  10. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163
  11. Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17:1695–1702
  12. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure (Less of one, more the other?). Am J Hypertens. 1988;1:335–347
  13. Barker DJ, Osmond C, Forsen TJ, et al. Trajectories of growth among children who have coronary events as adults. N Engl J Med. 2005;353:1802–1809
  14. Foster MC, Hwang S-J, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis. 2008;52:39–48
  15. Poggio ED, Rule AD. Can we do better than a single estimated GFR threshold when screening for chronic kidney disease?. Kidney Int. 2007;72:534–536
  16. Calabro P, Yeh ET. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. Curr Hypertens Rep. 2008;10:32–38
  17. Ritz E. Metabolic syndrome and kidney disease. Blood Purif. 2008;26:59–62
  18. Klein S, Fontana L, Young VL, Coggan AR, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549–2557
  19. Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52:29–38
  20. Smith HW. The Kidney—Structure and Function in Health and Disease. In: Oxford, UK: Oxford University Press; 1964;p. 543
  21. Bosma RJ, van der Heide JJ, Oosterop EJ, et al. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int. 2004;65:259–265
  22. Tomaszewski M, Charchar FJ, Maric C, et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int. 2007;71:816–821
  23. Krikken JA, Lely AT, Bakker SJ, Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int. 2007;71:260–265
  24. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol. 2007;293:C509–C536
  25. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625–633
  26. Dengel DR, Goldberg AP, Mayuga RS, et al. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension. 1996;28:127–132
  27. Hall JE, Brands MW, Mizelle HL, et al. Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol. 1991;260:F663–F669
  28. D'Agati VD, Markowitz GS. Supersized kidneys: Lessons from the preclinical obese kidney. Kidney Int. 2008;73:909–910
  29. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;339:1448–1456
  30. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  31. Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis. 2006;13:365–373
  32. Serra A, Romero R, Lopez D, Navarro M, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947–955
  33. Pinto-Sietsma SJ, Navis G, Janssen WM, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41:733–741
  34. Romero-Corral A, Lopez-Jimenez F, Boarin S, Sierra-Johnson J, Somers VK. Normal weight obesity: A risk factor for cardiometabolic dysregulations. J Am Coll Cardiol. 2008;51(suppl 1):A350;abstr 814-4
  35. Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens. 2006;24:1157–1163
  36. de Boer IH, Steffes MW. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes. J Am Soc Nephrol. 2007;18:1036–1037
  37. Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension. 2004;43:358–374
  38. Nagase M, Yoshida S, Shibata S, et al. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol. 2006;17:3438–3446
  39. Nagase M, Shibata S, Yoshida S, et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension. 2006;47:1084–1093
  40. Shibata S, Nagase M, Yoshida S, et al. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension. 2007;49:355–364
  41. Bakker SJ, Gansevoort RT, de Zeeuw D. Metabolic syndrome: a fata morgana?. Nephrol Dial Transplant. 2007;22:15–20
  42. Nagai Y, Yao L, Kobori H, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol. 2005;16:574–575
  43. Mykkanen L, Zaccaro DJ, Wagenknecht LE, et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes. 1998;47:793–800
  44. Brantsma AH, Bakker SJ, Hillege HL, et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care. 2005;28:2525–2530
  45. Caramori ML, Hansen BC, Mauer M, et al: Renal structural-functional relationships in spontaneously obese rhesus monkeys (RhM). Renal Week 2007: American Society of Nephrology Annual Meeting, San Francisco, CA, October 31 to November 5, 2007 (abstr F-PO331)
  46. Sanches FMR, Avesani CM, Kamimura MA, et al. Waist circumference and visceral fat in CKD: A cross-sectional study. Am J Kidney Dis. 2008;52:66–73
  47. Odamaki M, Furuya R, Ohkawa S, et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant. 1999;14:2427–2432
  48. Yamauchi T, Kuno T, Takada H, et al. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant. 2003;18:1842–1847
  49. Chen H-M, Li S-J, Chen H-P, Wang Q-W, Li L-S, Liu Z-H. Obesity-related glomerulopathy in China: A case series of 90 patients. Am J Kidney Dis. 2008;52:58–65

PII: S0272-6386(08)00876-7

doi: 10.1053/j.ajkd.2008.05.002

American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 1-6 , July 2008

Article Tools